Dexamethasone monotherapy

DRUG2 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Primary Immune ThrombocytopeniaPrimary Immune Thrombocytopenia (ITP)

Phase 2

A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

RecruitingNCT06658834

Institute of Hematology & Blood Diseases Hospital, ChinaPrimary Immune Thrombocytopenia

Start: 2024-06-01End: 2026-08-30Target: 129Updated: 2024-10-26

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

RecruitingNCT06992128

Institute of Hematology & Blood Diseases Hospital, ChinaPrimary Immune Thrombocytopenia (ITP)

Start: 2025-05-22End: 2028-08-31Target: 129Updated: 2025-05-28